Sfoglia per Autore
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study
2017-01-01 Roccatello, Dario; Sciascia, Savino; Rossi, Daniela; Alpa, Mirella; Naretto, Carla; Radin, Massimo; Fenoglio, Roberta; Baldovino, Simone; Menegatti, Elisa
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study
2017-01-01 Roccatello, Dario; Sciascia, Savino; Rossi, Daniela; Alpa, Mirella; Naretto, Carla; Radin, Massimo; Barreca, Antonella; Fenoglio, Roberta; Baldovino, Simone; Menegatti, Elisa
Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort
2018-01-01 Roccatello, D.; Sciascia, S.; Rossi, D.; Naretto, C.; Bazzan, M.; Solfietti, L.; Sandrone, M.; Radin, M.; Baldovino, S.; Menegatti, E.
Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosis
2020-01-01 Roccatello D.; Fenoglio R.; Baldovino S.; Naretto C.; Ferro M.; Barreca A.; Rossi D.; Sciascia S.
Rituximab in severe immunoglobulin-A vasculitis (Henoch-Schönlein) with aggressive nephritis
2020-01-01 Fenoglio, Roberta; Sciascia, Savino; Naretto, Carla; De Simone, Emanuele; Del Vecchio, Giulio; Ferro, Michela; Quattrocchio, Giacomo; Roccatello, Dario
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation
2020-01-01 Fenoglio R.; Baldovino S.; Ferro M.; Sciascia S.; Rabajoli G.; Quattrocchio G.; Beltrame G.; Naretto C.; Rossi D.; Alpa M.; Barreca A.; Papotti M.G.; Roccatello D.
Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience
2020-01-01 Roccatello, Dario; Fenoglio, Roberta; Naretto, Carla; Baldovino, Simone; Sciascia, Savino; Ferro, Michela; Rossi, Daniela
CD38 and anti-CD38 monoclonal antibodies in AL amyloidosis: Targeting plasma cells and beyond
2020-01-01 Roccatello D.; Fenoglio R.; Sciascia S.; Naretto C.; Rossi D.; Ferro M.; Barreca A.; Malavasi F.; Baldovino S.
Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli’s regimen in membranous nephropathy
2021-01-01 Fenoglio R.; Baldovino S.; Sciascia S.; De Simone E.; Del Vecchio G.; Ferro M.; Quattrocchio G.; Naretto C.; Roccatello D.
An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis
2021-01-01 Rossi, Daniela; Cecchi, Irene; Sciascia, Savino; Naretto, Carla; Alpa, Mirella; Roccatello, Dario
A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy
2021-01-01 Roccatello D.; Sciascia S.; Naretto C.; Alpa M.; Fenoglio R.; Ferro M.; Quattrocchio G.; Rubini E.; Rahbani E.; Rossi D.
Renal involvement as a unique manifestation of hemophagocytic syndrome
2022-01-01 Roccatello, Dario; Sciascia, Savino; Barreca, Antonella; Naretto, Carla; Alpa, Mirella; Quattrocchio, Giacomo; Radin, Massimo; Fenoglio, Roberta
Recognizing the new disorder "idiopathic hypocryoglobulinaemia" in patients with previously unidentified clinical conditions
2022-01-01 Roccatello, Dario; Sciascia, Savino; Naretto, Carla; Barreca, Antonella; Solfietti, Laura; Battaglia, Laura; Viziello, Lucia; Fenoglio, Roberta; Rossi, Daniela
Daratumumab monotherapy for refractory lupus nephritis
2023-01-01 Roccatello, Dario; Fenoglio, Roberta; Caniggia, Ilaria; Kamgaing, Joelle; Naretto, Carla; Cecchi, Irene; Rubini, Elena; Rossi, Daniela; De Simone, Emanuele; Del Vecchio, Giulio; Cozzi, Martina; Sciascia, Savino
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study | 2017 | Roccatello, Dario; Sciascia, Savino; Rossi, Daniela; Alpa, Mirella; Naretto, Carla; Radin, Massimo; Fenoglio, Roberta; Baldovino, Simone; Menegatti, Elisa | |
| High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study | 2017 | Roccatello, Dario; Sciascia, Savino; Rossi, Daniela; Alpa, Mirella; Naretto, Carla; Radin, Massimo; Barreca, Antonella; Fenoglio, Roberta; Baldovino, Simone; Menegatti, Elisa | |
| Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort | 2018 | Roccatello, D.; Sciascia, S.; Rossi, D.; Naretto, C.; Bazzan, M.; Solfietti, L.; Sandrone, M.; Radin, M.; Baldovino, S.; Menegatti, E. | |
| Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosis | 2020 | Roccatello D.; Fenoglio R.; Baldovino S.; Naretto C.; Ferro M.; Barreca A.; Rossi D.; Sciascia S. | |
| Rituximab in severe immunoglobulin-A vasculitis (Henoch-Schönlein) with aggressive nephritis | 2020 | Fenoglio, Roberta; Sciascia, Savino; Naretto, Carla; De Simone, Emanuele; Del Vecchio, Giulio; Ferro, Michela; Quattrocchio, Giacomo; Roccatello, Dario | |
| Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation | 2020 | Fenoglio R.; Baldovino S.; Ferro M.; Sciascia S.; Rabajoli G.; Quattrocchio G.; Beltrame G.; Naretto C.; Rossi D.; Alpa M.; Barreca A.; Papotti M.G.; Roccatello D. | |
| Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience | 2020 | Roccatello, Dario; Fenoglio, Roberta; Naretto, Carla; Baldovino, Simone; Sciascia, Savino; Ferro, Michela; Rossi, Daniela | |
| CD38 and anti-CD38 monoclonal antibodies in AL amyloidosis: Targeting plasma cells and beyond | 2020 | Roccatello D.; Fenoglio R.; Sciascia S.; Naretto C.; Rossi D.; Ferro M.; Barreca A.; Malavasi F.; Baldovino S. | |
| Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli’s regimen in membranous nephropathy | 2021 | Fenoglio R.; Baldovino S.; Sciascia S.; De Simone E.; Del Vecchio G.; Ferro M.; Quattrocchio G.; Naretto C.; Roccatello D. | |
| An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis | 2021 | Rossi, Daniela; Cecchi, Irene; Sciascia, Savino; Naretto, Carla; Alpa, Mirella; Roccatello, Dario | |
| A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy | 2021 | Roccatello D.; Sciascia S.; Naretto C.; Alpa M.; Fenoglio R.; Ferro M.; Quattrocchio G.; Rubini E.; Rahbani E.; Rossi D. | |
| Renal involvement as a unique manifestation of hemophagocytic syndrome | 2022 | Roccatello, Dario; Sciascia, Savino; Barreca, Antonella; Naretto, Carla; Alpa, Mirella; Quattrocchio, Giacomo; Radin, Massimo; Fenoglio, Roberta | |
| Recognizing the new disorder "idiopathic hypocryoglobulinaemia" in patients with previously unidentified clinical conditions | 2022 | Roccatello, Dario; Sciascia, Savino; Naretto, Carla; Barreca, Antonella; Solfietti, Laura; Battaglia, Laura; Viziello, Lucia; Fenoglio, Roberta; Rossi, Daniela | |
| Daratumumab monotherapy for refractory lupus nephritis | 2023 | Roccatello, Dario; Fenoglio, Roberta; Caniggia, Ilaria; Kamgaing, Joelle; Naretto, Carla; Cecchi, Irene; Rubini, Elena; Rossi, Daniela; De Simone, Emanuele; Del Vecchio, Giulio; Cozzi, Martina; Sciascia, Savino |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile